Literature DB >> 23559305

Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids.

Arne Warth1, Ludger Fink, Annette Fisseler-Eckhoff, Danny Jonigk, Marius Keller, German Ott, Ralf J Rieker, Peter Sinn, Stephan Söder, Alex Soltermann, Klaus Willenbrock, Wilko Weichert.   

Abstract

Evaluation of proliferative activity is a cornerstone in the classification of endocrine tumors; in pulmonary carcinoids, the mitotic count delineates typical carcinoid (TC) from atypical carcinoid (AC). Data on the reproducibility of manual mitotic counting and other methods of proliferation index evaluation in this tumor entity are sparse. Nine experienced pulmonary pathologists evaluated 20 carcinoid tumors for mitotic count (hematoxylin and eosin) and Ki-67 index. In addition, Ki-67 index was automatically evaluated with a software-based algorithm. Results were compared with respect to correlation coefficients (CC) and kappa values for clinically relevant grouping algorithms. Evaluation of mitotic activity resulted in a low interobserver agreement with a median CC of 0.196 and a median kappa of 0.213 for the delineation of TC from AC. The median CC for hotspot (0.658) and overall (0.746) Ki-67 evaluation was considerably higher. However, kappa values for grouped comparisons of overall Ki-67 were only fair (median 0.323). The agreement of manual and automated Ki-67 evaluation was good (median CC 0.851, median kappa 0.805) and was further increased when more than one participant evaluated a given case. Ki-67 staining clearly outperforms mitotic count with respect to interobserver agreement in pulmonary carcinoids, with the latter having an unacceptable low performance status. Manual evaluation of Ki-67 is reliable, and consistency further increases with more than one evaluator per case. Although the prognostic value needs further validation, Ki-67 might perspectively be considered a helpful diagnostic parameter to optimize the separation of TC from AC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23559305     DOI: 10.1007/s00428-013-1408-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  36 in total

Review 1.  Neuroendocrine tumors of the lung: an update.

Authors:  Natasha Rekhtman
Journal:  Arch Pathol Lab Med       Date:  2010-11       Impact factor: 5.534

2.  Assessment of interobserver variability in mitotic figure counting in different histological grades of oral squamous cell carcinoma.

Authors:  K Shailaja Yadav; Sudhir Gonuguntla; Kranti Kiran Reddy Ealla; Surekha Reddy Velidandla; C R Charan Reddy; M D Prasanna; Sanjay Reddy Bommu
Journal:  J Contemp Dent Pract       Date:  2012-05-01

3.  Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity.

Authors:  Coya Tapia; Heinz Kutzner; Thomas Mentzel; Spasenija Savic; Daniel Baumhoer; Katharina Glatz
Journal:  Am J Surg Pathol       Date:  2006-01       Impact factor: 6.394

4.  Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach.

Authors:  Tina Zahel; Sabine Krysa; Esther Herpel; Albrecht Stenzinger; Benjamin Goeppert; Peter Schirmacher; Hans Hoffmann; Philipp A Schnabel; Arne Warth
Journal:  Virchows Arch       Date:  2012-03       Impact factor: 4.064

Review 5.  Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature.

Authors:  G Fink; T Krelbaum; A Yellin; D Bendayan; M Saute; M Glazer; M R Kramer
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

6.  Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa.

Authors:  Sven Gunia; Christoph Kakies; Andreas Erbersdobler; Stefan Koch; Matthias May
Journal:  J Clin Pathol       Date:  2012-05-03       Impact factor: 3.411

7.  TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.

Authors:  G Rindi; M Falconi; C Klersy; L Albarello; L Boninsegna; M W Buchler; C Capella; M Caplin; A Couvelard; C Doglioni; G Delle Fave; L Fischer; G Fusai; W W de Herder; H Jann; P Komminoth; R R de Krijger; S La Rosa; T V Luong; U Pape; A Perren; P Ruszniewski; A Scarpa; A Schmitt; E Solcia; B Wiedenmann
Journal:  J Natl Cancer Inst       Date:  2012-04-23       Impact factor: 13.506

8.  Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study.

Authors:  Floyd H Gilles; C Jane Tavaré; Laurence E Becker; Peter C Burger; Allan J Yates; Ian F Pollack; Jonathan L Finlay
Journal:  Pediatr Dev Pathol       Date:  2007-09-25

9.  ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.

Authors:  Birgit Guldhammer Skov; Bente Holm; Anders Erreboe; Torsten Skov; Anders Mellemgaard
Journal:  J Thorac Oncol       Date:  2010-04       Impact factor: 15.609

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  26 in total

Review 1.  [Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia].

Authors:  P A Schnabel; K Junker
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  Ki-67 expression in pulmonary tumors-reply.

Authors:  Mark Kriegsmann; Arne Warth
Journal:  Transl Lung Cancer Res       Date:  2016-10

3.  What is better/reliable, mitosis counting or Ki67/MIB1 staining?

Authors:  Mark Kriegsmann; Arne Warth
Journal:  Transl Lung Cancer Res       Date:  2016-10

Review 4.  Lung neuroendocrine tumors: pathological characteristics.

Authors:  Luisella Righi; Gaia Gatti; Marco Volante; Mauro Papotti
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 5.  [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].

Authors:  A Warth
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

6.  Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.

Authors:  George Papaxoinis; Daisuke Nonaka; Ciara O'Brien; Benjamin Sanderson; Piotr Krysiak; Wasat Mansoor
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

7.  Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.

Authors:  V Clay; G Papaxoinis; B Sanderson; J W Valle; M Howell; A Lamarca; P Krysiak; P Bishop; D Nonaka; W Mansoor
Journal:  Clin Transl Oncol       Date:  2016-11-15       Impact factor: 3.405

Review 8.  Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.

Authors:  Giuseppe Pelosi; Mauro Papotti; Guido Rindi; Aldo Scarpa
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

Review 9.  Classification of pulmonary neuroendocrine tumors: new insights.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Sergio Harari; Adriana Albini; Enrica Bresaola; Caterina Marchiò; Federica Massa; Luisella Righi; Gaia Gatti; Nikolaos Papanikolaou; Namrata Vijayvergia; Fiorella Calabrese; Mauro Papotti
Journal:  Transl Lung Cancer Res       Date:  2017-10

Review 10.  [Gastroenteropancreatic neuroendocrine neoplasms. Role of biopsies].

Authors:  F Bergmann
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.